Renaissance Group LLC Vertex Pharmaceuticals Inc Transaction History

Renaissance Group LLC

$2.49 Billion
Q2 2025

A detailed history of Renaissance Group LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Renaissance Group LLC holds 1,519 shares of VRTX stock, worth $646,440. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,519

Previous 1,714 11.38%

Holding current value

$646,440

Previous $830,000 18.55%

% of portfolio

0.03%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$421.16 - $509.5 $82,126 - $99,352	-195 Reduced 11.38%	1,519 $676,000
Q1 2025 May 13, 2025	SELL	$402.49 - $513.76 $590,855 - $754,199	-1,468 Reduced 46.13%	1,714 $830,000
Q4 2024 Feb 13, 2025	SELL	$396.64 - $516.74 $16,658 - $21,703	-42 Reduced 1.3%	3,182 $1.28 Million
Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $32.3 Million - $35.5 Million	-70,255 Reduced 95.61%	3,224 $1.5 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $1.66 Million - $2.05 Million	-4,217 Reduced 5.43%	73,479 $34.4 Million
Q1 2024 Apr 26, 2024	SELL	$407.69 - $446.08 $4.58 Million - $5.01 Million	-11,236 Reduced 12.63%	77,696 $32.5 Million
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $1.15 Million - $1.37 Million	-3,339 Reduced 3.62%	88,932 $36.2 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $561,378 - $601,683	-1,660 Reduced 1.77%	92,271 $32.1 Million
Q2 2023 Aug 10, 2023	SELL	$314.42 - $351.91 $541,745 - $606,340	-1,723 Reduced 1.8%	93,931 $33.1 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $14,161 - $16,155	50 Added 0.05%	95,654 $30.1 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $213,748 - $240,467	-748 Reduced 0.78%	95,604 $27.6 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $2.72 Million - $3.03 Million	-9,916 Reduced 9.33%	96,352 $27.9 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $6.82 Million - $8.5 Million	-29,038 Reduced 21.46%	106,268 $29.9 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $2.26 Million - $2.66 Million	10,191 Added 8.15%	135,306 $35.3 Million
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $1.11 Million - $1.4 Million	6,265 Added 5.27%	125,115 $27.5 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $3.15 Million - $3.52 Million	17,365 Added 17.11%	118,850 $21.6 Million
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $955,261 - $1.13 Million	-5,095 Reduced 4.78%	101,485 $20.5 Million
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $4.87 Million - $5.68 Million	23,538 Added 28.34%	106,580 $22.9 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $858,677 - $1.15 Million	4,148 Added 5.26%	83,042 $19.6 Million
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $150,577 - $178,525	-589 Reduced 0.74%	78,894 $21.5 Million
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $17.9 Million - $23.5 Million	79,483 New	79,483 $23.1 Million

Others Institutions Holding VRTX

# of Institutions

1,784

Shares Held

236M

Call Options Held

1.95M

Put Options Held

1.14M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $109B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Group LLC with notifications on news.

Account

Renaissance Group LLC Vertex Pharmaceuticals Inc Transaction History